Abstract
No public abstract is available from the verified source records.
Agustín Bermejo Pastor, Beatriz Oda Plasencia-García, Begoña Zamora Benegas, Fernando García Lázaro, Rubén Catalán Barragán, Benedicto Crespo‐Facorro
Abstract
Authors
Institutions
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Treatment-resistant schizophrenia: treatment response and resistance in psychosis (TRRIP) Working Group Consensus Guidelines on diagnosis and terminology
10.1176/appi.ajp.2016.16050503 · 2017
Influence of inflammation on cytochromes P450 activity in adults: a systematic review of the literature
10.3389/fphar.2021.733935 · 2021
A method for estimating the probability of adverse drug reactions
10.1038/clpt.1981.154 · 1981
Termination of clozapine treatment due to medical reasons: when is it warranted and how can it be avoided?
10.4088/jcp.12r08064 · 2013
Reintroduction of clozapine after perforation of the large intestine—a case report and review of the literature
10.1345/aph.1s117 · 2013
Clozapine rechallenge in treatment-resistant schizophrenia: clinical and ethical considerations after ileus
10.1192/bjo.2025.10725 · 2025
Clozapine-induced gastrointestinal hypomotility: a 22-year bi-national pharmacovigilance study of serious or fatal ‘slow gut’ reactions, and comparison with international drug safety advice
10.1007/s40263-017-0448-6 · 2017
Clozapine-induced gastrointestinal hypomotility: presenting features and outcomes, UK pharmacovigilance reports, 1992-2017
10.1192/bjp.2022.24 · 2022
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
openalex
Confidence 95%
datacite
Confidence 0%
Clozapine and gastrointestinal hypomotility
10.1007/s40263-017-0481-5 · 2017
Clozapine-induced paralytic ileus: a case report
10.1177/2045125314524980 · 2014
Clozapine-induced paralytic ileus
2016
Clozapine optimization: a delphi consensus guideline from the treatment response and resistance in Psychosis Working Group
10.1093/schbul/sbad030 · 2023
Clozapine rechallenge following myocarditis: a systematic review of rechallenge cases
10.1017/s1092852924002219 · 2024
Multidisciplinary consensus on prevention, screening and monitoring of clozapine-associated myocarditis and clozapine rechallenge after myocarditis
2025
Clozapine rechallenge following myocarditis: a systematic review of rechallenge cases
10.1017/s1092852924002219 · doi-reference
Clozapine optimization: a delphi consensus guideline from the treatment response and resistance in Psychosis Working Group
10.1093/schbul/sbad030 · doi-reference
Clozapine-induced paralytic ileus: a case report
10.1177/2045125314524980 · doi-reference
Clozapine and gastrointestinal hypomotility
10.1007/s40263-017-0481-5 · doi-reference
Clozapine-induced gastrointestinal hypomotility: presenting features and outcomes, UK pharmacovigilance reports, 1992-2017
10.1192/bjp.2022.24 · doi-reference
Clozapine-induced gastrointestinal hypomotility: a 22-year bi-national pharmacovigilance study of serious or fatal ‘slow gut’ reactions, and comparison with international drug safety advice
10.1007/s40263-017-0448-6 · doi-reference
Clozapine rechallenge in treatment-resistant schizophrenia: clinical and ethical considerations after ileus
10.1192/bjo.2025.10725 · doi-reference
Reintroduction of clozapine after perforation of the large intestine—a case report and review of the literature
10.1345/aph.1s117 · doi-reference
Termination of clozapine treatment due to medical reasons: when is it warranted and how can it be avoided?
10.4088/jcp.12r08064 · doi-reference
A method for estimating the probability of adverse drug reactions
10.1038/clpt.1981.154 · doi-reference
Influence of inflammation on cytochromes P450 activity in adults: a systematic review of the literature
10.3389/fphar.2021.733935 · doi-reference
Treatment-resistant schizophrenia: treatment response and resistance in psychosis (TRRIP) Working Group Consensus Guidelines on diagnosis and terminology
10.1176/appi.ajp.2016.16050503 · doi-reference